Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi ($SNY)-Genzyme ($GENZ) impasse likely to stretch into 2011
Fierce Biotech
Friday, December 10, 2010 - 10:18am
tags:
Sanofi, M&A, Genzyme
Novartis's Failure With Zometa in Breast Cancer Stalls $1 Billion Booster
Bloomberg
Friday, December 10, 2010 - 10:15am
tags:
Novartis, breast cancer, Zometa
Study: Herceptin plus Tykerb helps women with early breast cancer more than either drug alone
Yahoo/AP
Friday, December 10, 2010 - 10:04am
tags:
breast cancer, Herceptin, Tykerb, GSK, Roche/Genentech
Pfizer withdrawing high blood pressure drug Thelin
Marketwatch
Friday, December 10, 2010 - 10:03am
tags:
Pfizer, Thelin
At Pfizer, a Messy Passing of the Mantle
Bloomberg Businessweek
Friday, December 10, 2010 - 10:02am
tags:
Pfizer, Pharma CEOs, Jeff Kindler, Ian Read
Bayer, Boehringer, Novartis vie for vet ops-sources
Reuters
Thursday, December 9, 2010 - 8:22pm
tags:
animal health, Bayer, Boehringer Ingelheim, Novartis, Merck, Sanofi
Martek falls on earnings forecast
Marketwatch
Thursday, December 9, 2010 - 8:19pm
tags:
Martek, earnings
Four Biotechs Positioned for Strong 2010 Finish
Seeking Alpha
Thursday, December 9, 2010 - 5:41pm
tags:
Inhibitex, Corcept Therapeutics, Cytokinetics, Lexicon Pharmaceuticals
Pfizer Details Severance Package for Kindler
NY Times, NY
Thursday, December 9, 2010 - 5:38pm
tags:
severance, Pfizer, Jeff Kindler, Pfizer CEOs
J&J Stock Flat on Downgrade, Rolaids Recall
TheStreet.com
Thursday, December 9, 2010 - 5:37pm
tags:
recalls, Rolaids, JNJ
IPads Are Latest Weapon in Medical Sales
WSJ Online
Thursday, December 9, 2010 - 1:26pm
tags:
iPad, Abbott Laboratories, Medtronic, Boston Scientific
Abbott Sales Reps Accused of Rifling Through Patients’ Medical Records
BNET Pharma
Thursday, December 9, 2010 - 1:24pm
tags:
Abbott Laboratories, patient records, drug reps, Kos, Niaspan
Novartis to Withdraw Expanded Zometa Approval Request After Trial Failure
Bloomberg
Thursday, December 9, 2010 - 1:21pm
tags:
Novartis, Zometa, breast cancer
ED Drug Could Support Vivus
Yahoo/Zacks.com
Thursday, December 9, 2010 - 12:22pm
tags:
erectile dysfunction, Vivus, Pfizer, GSK, Avanafil
Investors Revolt Against Charles River
Minyanville
Thursday, December 9, 2010 - 12:15pm
tags:
Charles River Laboratories, investors
A Tale of Two Pharmas: Outlooks for Lilly and Merck
Seeking Alpha
Thursday, December 9, 2010 - 12:10pm
tags:
Eli Lilly, Merck
Good News for Alkermes' Pipeline
Yahoo/Zacks.com
Thursday, December 9, 2010 - 12:09pm
tags:
Alkermes, JNJ
Pfizer, Novartis, AstraZeneca Cancer Drugs Increase Heart Risks
Bloomberg
Thursday, December 9, 2010 - 12:08pm
tags:
Pfizer, Novartis, AstraZeneca, Aromasin, Femara, Arimidex
Orexigen Approval Shows That Diversification Strategy Can Work
Seeking Alpha
Thursday, December 9, 2010 - 10:55am
tags:
Orexigen, FDA, Contrave
Drug indexes flat; Teva climbs on drug study
Marketwatch
Thursday, December 9, 2010 - 10:35am
tags:
Teva Pharmaceuticals, drug stocks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.